Clinical Application of Therapies Targeting VEGF

被引:48
作者
Yancopoulos, George D. [1 ]
机构
[1] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
关键词
ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; DIABETIC-RETINOPATHY; TUMOR-GROWTH; ANGIOGENESIS; MITOGEN; FLUID;
D O I
10.1016/j.cell.2010.09.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:13 / 16
页数:4
相关论文
共 15 条
[1]   INCREASED VASCULAR ENDOTHELIAL GROWTH-FACTOR LEVELS IN THE VITREOUS OF EYES WITH PROLIFERATIVE DIABETIC-RETINOPATHY [J].
ADAMIS, AP ;
MILLER, JW ;
BERNAL, MT ;
DAMICO, DJ ;
FOLKMAN, J ;
YEO, TK ;
YEO, KT .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (04) :445-450
[2]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[3]   Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment Efficacy [J].
Bagri, Anil ;
Berry, Leanne ;
Gunter, Bert ;
Singh, Mallika ;
Kasman, Ian ;
Damico, Lisa A. ;
Hong Xiang ;
Schmidt, Maike ;
Fuh, Germaine ;
Hollister, Beth ;
Rosen, Oliver ;
Plowman, Greg D. .
CLINICAL CANCER RESEARCH, 2010, 16 (15) :3887-3900
[4]  
CONNOLLY DT, 1989, J BIOL CHEM, V264, P20017
[5]   Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer [J].
Ferrara, N ;
Hillan, KJ ;
Gerber, HP ;
Novotny, W .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) :391-400
[6]   Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration [J].
Ferrara, Napoleone ;
Damico, Lisa ;
Shams, Naveed ;
Lowman, Henry ;
Kim, Robert .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (08) :859-870
[7]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[8]   VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation [J].
Gerber, HP ;
Vu, TH ;
Ryan, AM ;
Kowalski, J ;
Werb, Z ;
Ferrara, N .
NATURE MEDICINE, 1999, 5 (06) :623-628
[9]  
Gerber HP, 1999, DEVELOPMENT, V126, P1149
[10]   VASCULAR-PERMEABILITY FACTOR, AN ENDOTHELIAL-CELL MITOGEN RELATED TO PDGF [J].
KECK, PJ ;
HAUSER, SD ;
KRIVI, G ;
SANZO, K ;
WARREN, T ;
FEDER, J ;
CONNOLLY, DT .
SCIENCE, 1989, 246 (4935) :1309-1312